Modeling the Role of Oscillator Flow and Dynamic Mechanical Conditioning on Dense Connective Tissue Formation in Mesenchymal Stem Cell-Derived Heart Valve Tissue Engineering.
作者信息
Soares João S, B Le Trung, Sotiropoulos Fotis, S Sacks Michael
机构信息
Institute for Computational Engineering and Sciences, University of Texas at Austin , Austin, TX 78712.
Saint Anthony Falls Laboratory, Department of Civil Engineering, University of Minnesota , Minneapolis, MN 55414.
出版信息
J Med Device. 2013 Dec;7(4):0409271-409272. doi: 10.1115/1.4025984. Epub 2013 Dec 5.
Abstract
摘要
相似文献
1
Modeling the Role of Oscillator Flow and Dynamic Mechanical Conditioning on Dense Connective Tissue Formation in Mesenchymal Stem Cell-Derived Heart Valve Tissue Engineering.
J Med Device. 2013 Dec;7(4):0409271-409272. doi: 10.1115/1.4025984. Epub 2013 Dec 5.
2
A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions.
J Biomech Eng. 2014 Dec;136(12):121009. doi: 10.1115/1.4028815.
3
Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Biomaterials. 2006 Dec;27(36):6083-95. doi: 10.1016/j.biomaterials.2006.07.045. Epub 2006 Aug 23.
4
Computational simulations predict a key role for oscillatory fluid shear stress in de novo valvular tissue formation.
J Biomech. 2014 Nov 7;47(14):3517-23. doi: 10.1016/j.jbiomech.2014.08.028. Epub 2014 Sep 16.
5
Non-physiologic Bioreactor Processing Conditions for Heart Valve Tissue Engineering.
Cardiovasc Eng Technol. 2019 Dec;10(4):628-637. doi: 10.1007/s13239-019-00438-x. Epub 2019 Oct 24.
6
A "sweet-spot" for fluid-induced oscillations in the conditioning of stem cell-based engineered heart valve tissues.
J Biomech. 2017 Dec 8;65:40-48. doi: 10.1016/j.jbiomech.2017.09.035. Epub 2017 Oct 7.
7
Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach.
Ann Biomed Eng. 2005 Dec;33(12):1778-88. doi: 10.1007/s10439-005-8025-4.
8
Design and efficacy of a single-use bioreactor for heart valve tissue engineering.
J Biomed Mater Res B Appl Biomater. 2017 Feb;105(2):249-259. doi: 10.1002/jbm.b.33552. Epub 2015 Oct 15.
9
Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
J Heart Valve Dis. 2008 Jul;17(4):446-55; discussion 455.
10
Periodontal ligament cells cultured under steady-flow environments demonstrate potential for use in heart valve tissue engineering.
Tissue Eng Part A. 2013 Feb;19(3-4):458-66. doi: 10.1089/ten.TEA.2012.0149. Epub 2012 Oct 19.
本文引用的文献
1
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.
Biomaterials. 2010 Feb;31(6):1114-25. doi: 10.1016/j.biomaterials.2009.10.019. Epub 2009 Nov 26.
2
A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology.
Ann Biomed Eng. 2008 May;36(5):700-12. doi: 10.1007/s10439-008-9447-6. Epub 2008 Feb 6.
3
Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Biomaterials. 2006 Dec;27(36):6083-95. doi: 10.1016/j.biomaterials.2006.07.045. Epub 2006 Aug 23.
4
The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Biomaterials. 2005 Jan;26(2):175-87. doi: 10.1016/j.biomaterials.2004.02.035.
5
Tissue engineering of heart valves -- current aspects.
Thorac Cardiovasc Surg. 2002 Jun;50(3):184-93. doi: 10.1055/s-2002-32406.
Zotero 插件